Omaxe Ltd
Omaxe Ltd (OMAXE) last reported results for the quarter ended Jun 2026, with sales of ₹406 crore and net profit of ₹1.3 crore. The stock last traded at ₹108, a market capitalisation of ₹1,981 crore. Over the past 52 weeks the stock has ranged between ₹62.5 and ₹139. Figures are as of 6 Oct 2026 and are not real time.
Omaxe Ltd share price and key metrics
- Current price
- ₹108
- Market cap
- ₹1,981 cr
- Book value
- ₹-49.3
- ROE
- %
- ROCE
- -112%
- Dividend yield
- 0.00%
- 52w high / low
- 139/62.5
Metrics as of 6 Oct 2026. Not real time.
Track Omaxe Ltd
Cruxal reads every Omaxe Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Omaxe Ltd growth and returns
- 10 Years
- -1%
- 5 Years
- 21%
- 3 Years
- 17%
- TTM
- -8%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 30%
- 10 Years
- -5%
- 5 Years
- 6%
- 3 Years
- 14%
- 1 Year
- 28%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Omaxe Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹406 cr, up 43.9% from ₹282 cr a year earlier. Net profit turned positive at ₹1.3 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 389 | 289 | 541 | 282 | 321 | 302 | 349 | 406 |
| Expenses | 613 | 416 | 647 | 452 | 490 | 457 | 550 | 399 |
| Operating profit | -223.97 | -126.75 | -106.09 | -169.64 | -169.06 | -155.2 | -201.94 | 7.32 |
| OPM % | -57.55% | -43.87% | -19.60% | -60.10% | -52.70% | -51.42% | -57.94% | 1.80% |
| Other income | 9.14 | 11.45 | 11.77 | 15.79 | 25.54 | 17.21 | 27.79 | 32.77 |
| Interest | 44.64 | 56.95 | 51.33 | 67.03 | 64.68 | 53.86 | 69.54 | 27.08 |
| Depreciation | 7.46 | 10.43 | 11.6 | 7.21 | 8.26 | 8.99 | 10.05 | 7.88 |
| Profit before tax | -266.93 | -182.68 | -157.25 | -228.09 | -216.46 | -200.84 | -253.74 | 5.13 |
| Tax % | -10.28% | -17.74% | -5.46% | -18.55% | -23.12% | -23.72% | -24.56% | 74.66% |
| Net profit | -239.48 | -150.28 | -148.67 | -185.77 | -166.42 | -153.2 | -191.42 | 1.3 |
| EPS (₹) | -13.10 | -8.23 | -8.11 | -10.16 | -9.11 | -8.38 | -10.46 | 0.05 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Omaxe Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,627 | 1,839 | 1,167 | 1,121 | 476 | 618 | 773 | 1,614 | 1,561 | 1,251 | 1,377 |
| Operating profit | 284 | 260 | 128 | 198 | -119 | -47 | -303 | -343 | -608 | -696 | -519 |
| OPM % | 17% | 14% | 11% | 18% | -25% | -8% | -39% | -21% | -39% | -56% | -38% |
| Net profit | 105 | 85 | 49 | -97 | -235 | -162 | -351 | -406 | -685 | -697 | -510 |
| EPS (₹) | 5.58 | 4.59 | 2.68 | -5.32 | -12.86 | -8.72 | -19.02 | -22.01 | -37.51 | -38.10 | -27.90 |
TTM is the trailing twelve months to the most recent quarter.
Omaxe Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 |
| Reserves | 1,936 | 2,014 | 1,558 | 1,456 | 1,222 | 1,062 | 715 | 298 | -388 | -1,084 |
| Borrowings | 1,503 | 1,802 | 1,856 | 1,672 | 1,530 | 1,128 | 1,107 | 796 | 796 | 1,466 |
| Other liabilities | 4,704 | 4,129 | 7,163 | 7,239 | 8,108 | 9,545 | 11,555 | 12,546 | 14,287 | 15,958 |
| Total liabilities | 8,326 | 8,128 | 10,760 | 10,549 | 11,042 | 11,918 | 13,560 | 13,822 | 14,877 | 16,522 |
| Fixed assets | 604 | 604 | 599 | 747 | 671 | 627 | 582 | 565 | 606 | 170 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 12 | 12 | 12 | 12 | 13 | 14 | 29 | 21 | 18 |
| Other assets | 7,710 | 7,512 | 10,149 | 9,789 | 10,359 | 11,278 | 12,964 | 13,228 | 14,251 | 16,334 |
| Total assets | 8,326 | 8,128 | 10,760 | 10,549 | 11,042 | 11,918 | 13,560 | 13,822 | 14,877 | 16,522 |
As reported by the company. Total assets equal total liabilities by construction.
Omaxe Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 121 | 19 | 400 | 638 | 566 | 783 | 469 | 987 | 1,007 | 212 |
| Cash from investing | 20 | 21 | 16 | 106 | 23 | -22 | -142 | -64 | -126 | 60 |
| Cash from financing | -173 | -35 | -435 | -783 | -517 | -740 | -262 | -924 | -770 | -82 |
| Net cash flow | -32 | 4 | -18 | -39 | 72 | 21 | 65 | -1 | 111 | 189 |
| Free cash flow | 102 | 5 | 393 | 636 | 570 | 782 | 458 | 985 | 999 | 186 |
| CFO / operating profit | 58% | 21% | 336% | 332% | -468% | -1,695% | -149% | -290% | -174% | -38% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Omaxe Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 10% | 8% | 4% | 5% | -5% | -3% | -16% | -23% | -62% | -112% |
| Debtor days | 235 | 158 | 110 | 111 | 298 | 227 | 182 | 81 | 73 | 77 |
| Inventory days | — | — | — | — | — | — | — | 16,214 | — | — |
| Days payable | — | — | — | — | — | — | — | 1,755 | — | — |
| Cash conversion cycle | 235 | 158 | 110 | 111 | 298 | 227 | 182 | 14,539 | 73 | 77 |
| Working capital days | 547 | 461 | 532 | 508 | 911 | 424 | 156 | -62 | -336 | -420 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Omaxe Ltd shareholding pattern
Promoters held 74.14% at Jun 2026, broadly unchanged since Jun 2025. FIIs 5.33% and DIIs 1.40%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.14% | 74.14% | 74.14% | 74.14% | 74.14% | 74.14% | 74.14% | 74.14% |
| FIIs | 7.19% | 7.27% | 7.38% | 6.66% | 6.06% | 5.11% | 6.18% | 5.33% |
| DIIs | 2.29% | 2.29% | 2.29% | 2.26% | 1.56% | 1.56% | 1.56% | 1.40% |
| Public | 16.39% | 16.30% | 16.18% | 16.93% | 18.23% | 19.20% | 18.12% | 19.13% |
| No. of shareholders | 49,450 | 48,084 | 48,385 | 48,598 | 49,331 | 48,463 | 47,585 | 47,595 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Omaxe Ltd corporate filings
- Omaxe Limited's Rating Withdrawal by Infomerics and No Financial Impact DisclosureCompany Updatelow impact
Cruxal's analysis: Omaxe Limited has received a rating withdrawal notice from Infomerics Valuation and…
Read the full analysis - Omaxe Ltd announces sale of 40% equity shares in Aquarise Developers Pvt Ltd held by its step-down subsidiary Dinkar Realcon Pvt LtdCompany Updatelow impact
Cruxal's analysis: On October 1, 2026, Omaxe Ltd disclosed the sale of 40% of its stake in Aquarise…
Read the full analysis - Guild Builders Private Limited revokes pledge on 77.31 lakh shares of Omaxe Limited, reducing encumbrance to 4.23% of total share capitalInsider Trading / SASThigh impact
Cruxal's analysis: Guild Builders Private Limited, the promoter holding company of Omaxe Limited, has…
Read the full analysis - Omaxe Limited announces successful passing of all resolutions at 37th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Omaxe Limited has successfully concluded its 37th Annual General Meeting held on…
Read the full analysis - SEBI Restrains Omaxe Limited from Securities Market for Three Months Over Minimum Public Shareholding Non-ComplianceCompany Updatehigh impact
Cruxal's analysis: Omaxe Limited has received a SEBI order dated September 24, 2026, imposing a three-month…
Read the full analysis - Omaxe Limited concludes 37th Annual General Meeting; results of voting to be declared by September 29, 2026AGM/EGMlow impact
Cruxal's analysis: Omaxe Limited held its 37th Annual General Meeting on September 25, 2026, via video…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: Please find enclosed herewith a copy of intimation w.r.t. Closure of Trading Window.
Read the full analysis - Omaxe Ltd files routine intimation regarding newspaper publication of financial disclosuresCompany Updatelow impact
Cruxal's analysis: Omaxe Ltd has submitted a formal intimation regarding the publication of its financial…
Read the full analysis - Omaxe Limited announces resignation of Vice President – PMOCompany Updatelow impact
Cruxal's analysis: Omaxe Limited has formally disclosed the resignation of Mr. Neeraj Arora, who served as…
Read the full analysis - Omaxe Limited announces resignation of Vice President – PMOCompany Updatelow impact
Cruxal's analysis: Omaxe Limited has formally notified the stock exchanges regarding the resignation of Mr…
Read the full analysis - Omaxe Limited: SAT dismisses appeal against SEBI order regarding alleged regulatory violationsCompany Updatemedium impact
Cruxal's analysis: Omaxe Limited has informed the exchanges that the Securities Appellate Tribunal (SAT) has…
Read the full analysis - Omaxe Ltd files routine newspaper publication regarding corporate disclosuresCompany Updatelow impact
Cruxal's analysis: Omaxe Ltd has submitted copies of newspaper advertisements as part of its regulatory…
Read the full analysis - Omaxe Ltd files Business Responsibility and Sustainability Report (BRSR) for FY 2025-26Otherslow impact
Cruxal's analysis: Omaxe Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for…
Read the full analysis - Omaxe Ltd submits response to exchange regarding rumour verificationCompany Updatelow impact
Cruxal's analysis: Omaxe Ltd has filed a formal response to the stock exchange in compliance with Regulation…
Read the full analysis - Omaxe Ltd files routine shareholder communication under Regulation 36(1)(b)Company Updatelow impact
Cruxal's analysis: Omaxe Ltd has submitted a formal intimation regarding a letter to shareholders in…
Read the full analysis - Omaxe Limited Announces 37th Annual General Meeting for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Omaxe Limited has scheduled its 37th Annual General Meeting (AGM) for Friday, September…
Read the full analysis - Omaxe Ltd clarifies recent stock price movement in response to exchange queryCompany Updatelow impact
Cruxal's analysis: Omaxe Ltd has submitted a formal reply to the stock exchange regarding recent volatility…
Read the full analysis - Omaxe Ltd publishes mandatory newspaper advertisements regarding corporate disclosuresCompany Updatelow impact
Cruxal's analysis: Omaxe Ltd has released copies of newspaper advertisements as part of its routine…
Read the full analysis - Omaxe Ltd announces new project launch and receipt of regulatory approvalsCompany Updatelow impact
Cruxal's analysis: Omaxe Ltd has issued an intimation regarding the launch of a new project and the receipt…
Read the full analysis - Omaxe Ltd files routine intimation regarding newspaper publicationCompany Updatelow impact
Cruxal's analysis: Omaxe Ltd has submitted a formal intimation regarding the publication of a notice in…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.